In the present study, COL1A1, COL1A2, COL4A1, and COL6A3 were found to be precisely expressed by collagen genes in human gastric lesions and could distinguish between malignant and premalignant lesions, identifying these genes as predictive biomarkers and/or therapeutic targets for GC [41]. This evidence concerns the gene COL6A3 and gastric cancer.